Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study. (2022)
Attributed to:
Mendelian randomization to hypothesis-free causal inference
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00125-022-05743-0
PubMed Identifier: 35902387
Publication URI: http://europepmc.org/abstract/MED/35902387
Type: Journal Article/Review
Volume: 65
Parent Publication: Diabetologia
Issue: 10
ISSN: 0012-186X